Teladoc Health (NYSE:TDOC) PT Lowered to $10.00

Teladoc Health (NYSE:TDOC) had its price objective dropped by equities researchers at Evercore ISI from $14.00 to $10.00 in a report released on Tuesday, Benzinga reports. The firm currently has an “in-line” rating on the health services provider’s stock. Evercore ISI’s price target suggests a potential upside of 11.67% from the stock’s current price.

Several other equities research analysts also recently commented on TDOC. Oppenheimer dropped their price objective on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating on the stock in a report on Friday, April 26th. Royal Bank of Canada lowered their price target on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, April 26th. Bank of America lowered their price target on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a report on Tuesday, May 14th. Barclays lowered their price target on shares of Teladoc Health from $25.00 to $20.00 and set an “overweight” rating on the stock in a report on Friday, April 26th. Finally, Wells Fargo & Company lowered their price target on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a report on Monday, April 29th. Thirteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and an average price target of $17.97.

Teladoc Health Price Performance

TDOC opened at $8.96 on Tuesday. The firm has a market cap of $1.52 billion, a P/E ratio of -6.35 and a beta of 0.94. Teladoc Health has a fifty-two week low of $8.73 and a fifty-two week high of $30.41. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. The firm has a 50-day moving average of $10.93 and a 200 day moving average of $15.09.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The business had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. Teladoc Health’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the company earned ($0.37) earnings per share. On average, research analysts expect that Teladoc Health will post -1.05 EPS for the current year.

Insider Activity at Teladoc Health

In related news, insider Laizer Kornwasser sold 10,411 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $132,115.59. Following the sale, the insider now directly owns 86,070 shares of the company’s stock, valued at $1,092,228.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Teladoc Health news, Director Karen L. Daniel sold 9,834 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the transaction, the director now directly owns 36,995 shares in the company, valued at $440,240.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The disclosure for this sale can be found here. Insiders have sold 32,592 shares of company stock valued at $397,064 over the last three months. 0.95% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of TDOC. Scotia Capital Inc. grew its position in Teladoc Health by 123.5% during the third quarter. Scotia Capital Inc. now owns 17,742 shares of the health services provider’s stock valued at $330,000 after acquiring an additional 9,803 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Teladoc Health by 12.4% in the third quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock worth $5,598,000 after purchasing an additional 33,287 shares during the last quarter. Sunbelt Securities Inc. grew its holdings in shares of Teladoc Health by 3.7% in the third quarter. Sunbelt Securities Inc. now owns 24,877 shares of the health services provider’s stock worth $462,000 after purchasing an additional 899 shares during the last quarter. Ignite Planners LLC grew its holdings in shares of Teladoc Health by 10.6% in the fourth quarter. Ignite Planners LLC now owns 12,450 shares of the health services provider’s stock worth $273,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Westside Investment Management Inc. grew its holdings in shares of Teladoc Health by 46.2% in the fourth quarter. Westside Investment Management Inc. now owns 4,112 shares of the health services provider’s stock worth $89,000 after purchasing an additional 1,300 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.